-
Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response to immune checkpoint inhibitors in urothelial cancer
Rijnders, M., Nakauma-González, J. A., Robbrecht, D. G. J., Gil-Jimenez, A., Balcioglu, H. E., Oostvogels, A. A. M., Aarts, M. J. B., Boormans, J. L., Hamberg, P., van der Heijden, M. S., Szabados, B. E., van Leenders, G. J. L. H., Mehra, N., Voortman, J., Westgeest, H. M., de Wit, R., van der Veldt, A. A. M., Debets, R. & Lolkema, M. P., 1 Dec 2024, In: Nature communications. 15, 1, 1349.Research output: Contribution to journal › Article › Academic › peer-review
-
Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors
Gil-Jimenez, A., van Dijk, N., Vos, J. L., Lubeck, Y., van Montfoort, M. L., Peters, D., Hooijberg, E., Broeks, A., Zuur, C. L., van Rhijn, B. W. G., Vis, D. J., van der Heijden, M. S. & Wessels, L. F. A., 1 Dec 2024, In: Nature communications. 15, 1, 2538.Research output: Contribution to journal › Article › Academic › peer-review
-
A multiplex UPLC-MS/MS method for the quantification of three PD-L1 checkpoint inhibitors, atezolizumab, avelumab, and durvalumab, in human serum
Buitelaar, P. L. M., de Jong, K. A. M., Aardenburg, L., van der Heijden, M. S., Huitema, A. D. R., Beijnen, J. H. & Rosing, H., 15 Jun 2024, In: Journal of Pharmaceutical and Biomedical Analysis. 243, 116108.Research output: Contribution to journal › Article › Academic › peer-review
- All publications